Fig.3

Fluctuating changes of genomic alterations during sequential chemotherapy. A: changes of percentages of TP53 and LRP1B mutations during treatment. B: fluctuating changes of TP53 and LRP1B frequency during treatment. C: involved mutation sites of TP53 and LRP1B